Pneumococcal infection among children before introduction of 13-valent pneumococcal conjugate vaccine, Cambodia

Emerging Infectious Diseases

Volumn 21, Issue 11, 2015, Pages 2080-2083

  Turner, Paul ^a,b,c   Turner, Claudia ^a,b,c   Suy, Kuong ^a   Soeng, Sona ^d   Ly, Sokeng ^d   Miliya, Thyl ^d   Goldblatt, David ^e   Day, Nicholas P J ^b,c  

^a Cambodia Oxford Medical Research Unit   (Cambodia)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Angkor Hospital for Children   (Cambodia)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLHYDROCUPREINE; PNEUMOCOCCUS VACCINE; VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; CAMBODIA; CHILD; CLINICAL EFFECTIVENESS; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PNEUMOCOCCAL INFECTION; SEROTYPE; VACCINATION; ADOLESCENT; PNEUMONIA, PNEUMOCOCCAL; PRESCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; CAMBODIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84944607417     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2111.150914     Document Type: Article

References (15)

1. World Health Organization. Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008 [cited 2014 Mar 9]. http://www.who.int/immunization/monitoring_surveillance/burden/ estimates/Pneumo_hib/en/
2. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10:e1001517. http://dx.doi.org/10.1371/journal.pmed.1001517
3. World Health Organization Coordinated Invasive Bacterial Vaccine Preventable Diseases (IB-VPD) Surveillance Network. Surveillance network case definitions [cited 2014 Dec 4]. http://www.who.int/immunization/monitoring_surveillance/ resources/IB-VPD_Case_Defs.pdf?ua=1
4. Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013;32:165-79. http://dx.doi.org/10.1016/j.vaccine.2013.08.062
5. Turner P, Turner C, Jankhot A, Helen N, Lee SJ, Day NP, et al. A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border. PLoS ONE. 2012;7:e38271. http://dx.doi.org/10.1371/ journal.pone.0038271
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. CLSI document M100-S23. Wayne (PA): The Institute; 2013.
7. von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014;371:1889-99. http://dx.doi.org/10.1056/NEJMoa1401914
8. Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008;8:785-95. http://dx.doi.org/10.1016/S1473-3099(08)70281-0
9. Mitchell PK, Lipsitch M, Hanage WP. Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci. Philos Trans R Soc Lond B Biol Sci. 2015;370:20140342. http://dx.doi.org/10.1098/rstb.2014.0342
10. Chewapreecha C, Harris SR, Croucher NJ, Turner C, Marttinen P, Cheng L, et al. Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet. 2014;46:305-9. http://dx.doi.org/10.1038/ng.2895
11. Schultsz C, Vien le M, Campbell JI, Chau NV, Diep TS, Hoang NV, et al. Changes in the nasal carriage of drug-resistant Streptococcus pneumoniae in urban and rural Vietnamese schoolchildren. Trans R Soc Trop Med Hyg. 2007;101:484-92. http://dx.doi.org/10.1016/j.trstmh.2006.08.010
12. Emary KR, Carter MJ, Pol S, Sona S, Kumar V, Day NP, et al. Urinary antibiotic activity in paediatric patients attending an outpatient department in north-western Cambodia. Trop Med Int Health. 2015;20:24-8. http://dx.doi.org/10.1111/tmi.12398
13. Thummeepak R, Leerach N, Kunthalert D, Tangchaisuriya U, Thanwisai A, Sitthisak S. High prevalence of multi-drug resistant Streptococcus pneumoniae among healthy children in Thailand. J Infect Public Health. 2015;8:274-81. http://dx.doi.org/10.1016/j.jiph.2014.11.002
14. Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15:301-9. http://dx.doi.org/10.1016/S1473-3099(14)71081-3
15. Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15:535-43. http://dx.doi.org/10.1016/ S1473-3099(15)70044-7